
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1075 | 1035 | 1105 | 1207 | 1496 | 1672 |
Fund Return | 7.47% | 3.49% | 10.46% | 6.46% | 8.4% | 5.28% |
Place in category | 256 | 440 | 236 | 163 | 262 | 166 |
% in Category | 31 | 57 | 31 | 28 | 46 | 46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pax Global Environmental Mrkts Inst | 2.1B | 2.81 | 5.08 | 8.37 | ||
Pax Balanced Individual Investor | 1.33B | 1.55 | 3.22 | 6.53 | ||
Pax Large Cap Fund Institutional | 1.27B | 0.16 | 5.74 | - | ||
Pax Balanced Institutional | 974.39M | 1.59 | 3.48 | 6.80 | ||
Pax Small Cap Institutional | 600.06M | -1.75 | 3.80 | 6.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 55.99B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.88B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 47.55B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 2.76 | 99.23 | -0.55% | |
AstraZeneca | GB0009895292 | 2.43 | 11,608.0 | -1.69% | |
HSBC | GB0005405286 | 2.30 | 881.60 | +0.63% | |
Schneider Electric | FR0000121972 | 2.18 | 231.75 | -2.22% | |
ASML Holding | NL0010273215 | 2.00 | 660.70 | -1.75% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review